Ro48-8684
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
3-(5-dipropylaminomethyloxazol-2-yl)-8-fluoro-5-methyl-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one
|
|
| Identifiers | |
| PubChem | CID 9866317 |
| ChemSpider | 8042008 |
| Chemical data | |
| Formula | C22H26FN5O2 |
| Molar mass | 411.472 |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (verify) | |
Ro48-8684 is a water-soluble benzodiazepine derivative developed by Hoffman-LaRoche in the 1990s, which was designed along with Ro48-6791 as an improved replacement for midazolam, but ultimately proved to have little advantages over the parent drug and has not been introduced into clinical practice.[1][2]
See also[edit]
References[edit]
- ^ van Gerven JM, Roncari G, Schoemaker RC, Massarella J, Keesmaat P, Kooyman H, Heizmann P, Zell M, Cohen AF, Dingemanse J. Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects. British Journal of Clinical Pharmacology. 1997 Nov;44(5):487-93. PMID 9384466
- ^ Albrecht S, Hering W, Ihmsen H, Schwilden H, Schüttler J. Pharmacokinetic-pharmacodynamic modeling in phase II of drug development. A comparative study with young and old volunteers with benzdiazepine as an example. (German) Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 1999 Oct;34(10):634-7. PMID 10548960
 |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
